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We report the outcomes of BioMed Central’s public consultation on implementing open data-compliant licensing
in peer-reviewed open access journals. Respondents (42) to the 2012 consultation were six to one in favor (29 in
support; 5 against; 8 abstentions) of changing our authors’ default open access copyright license agreement, to
introduce the Creative Commons CC0 public domain waiver for data published in BioMed Central’s journals. We
summarize the different questions we received in response to the consultation and our responses to them –
matters such as citation, plagiarism, patient privacy, and commercial use were raised. In light of the support for
open data in our journals we outline our plans to implement, in September 2013, a combined Creative Commons
Attribution license for published articles (papers) and Creative Commons CC0 waiver for published data.Introduction
Respondents to BioMed Central’s public consultation on
Open Data [1], which was open for comments from
September to November 2012, were six to one in favor of
adopting a new copyright system in journal publishing: a
system which should increase the efficiency of knowledge
discovery from the published literature, which requires
little change in scientists’ current behaviors to implement
while affecting nearly every article we publish in the
future, and which could be adopted by other publishers
for the benefit of science. Since the consultation we have
been investigating the different technical and procedural
approaches for implementing a new license agreement for
all BioMed Central journals, in collaboration with our previ-
ously established Publishing Open Data Working Group [2].
We are excited by the support for the proposals but
must also address any questions that are raised by our
authors and editors. Further below we summarize the
different questions we received and our responses to
them.
Central to the proposals, which we distributed for
public consultation, were to change BioMed Central’s
standard copyright license agreement for open access* Correspondence: stefan.busch@biomedcentral.com
2BioMed Central Ltd, 236 Gray’s Inn Road, London WC1X 8HB, UK
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Creative Commons Attribution License (http:/
distribution, and reproduction in any mediumarticles so that any data in published articles and in add-
itional files are published under the Creative Commons
CC0 waiver, rather than the Creative Commons Attribu-
tion license, CC-BY (for full details see [3]). Creative
Commons CC0 is a public domain dedication and means
that a person has dedicated a work “to the public do-
main by waiving all of his or her rights to the work
worldwide under copyright law, including all related and
neighboring rights, to the extent allowed by law” [4].Summary of responses to the consultation
See Table 1 for a summary of the responses and the pri-
mary stakeholder group of each respondent. We did not
seek consent for the responses received by email to be
published but have collated them and identified the
common questions which emerged in an anonymous
fashion. A number of these questions were anticipated
and discussed in our article in BMC Research Notes [3].
And while the questions were mostly valid with regard
to sharing and publication of data in general, the major-
ity did not apply in the context of the consultation,
which was purely about licensing of data already planned
to be made available freely online. We therefore need to
make it abundantly clear to authors that the proposed
change to our standard license agreement only affects
data which authors are already publishing open access,Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Table 1 Number of responses received to the
consultation, the primary stakeholder group of the
respondents and the number who supported, were
against or were neutral about the proposals






Support proposed change 29
Do not support proposed change 5
Abstained 8
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The questions fell largely into the following areas.
Question: Will commercial organizations benefit from
use of public domain data?
Response: It is already possible for commercial organi-
zations to use content published in open access journals
under the CC-BY license for their own benefit. BioMed
Central, and many other open access publishers, use
CC-BY as the default license for journal articles and
their supplementary material (additional files, which can
include data). The Open Access Scholarly Publishers As-
sociation (OASPA) strongly recommends use of CC-BY
[5] by all its members. Using CC0 for data contained in
published articles does not change the already existing
potential for commercial uses of the published work.
Moreover, permitting commercial use of open access
content enables all reuses, including sharing of content
on Wikipedia (which uses CC-BY ShareAlike 3.0) and
preservation of content by commercial organizations,
which could prove valuable [6] in the event of a pub-
lisher going out of business. The UK Government has
recognized the benefits to the wider economy and, ul-
timately, tax payers by making publicly-funded data
available openly to stimulate business innovation in
funding the start-up of the Open Data Institute [7],
which launched in 2012.
Applying CC0 to data published in journals is not
intended to change the numerous community or journal
data availability policies [8]. Authors and editors remain
in control of what data they choose to publish, unless
they are subject to a community-specific requirement
for data release.
Question: Will plagiarism increase?
Response: Plagiarism (unattributed copying) and the
potential for plagiarism has increased with digital access
to content [9], independent of content licenses. In schol-
arly publishing plagiarism usually occurs when text,rather than data, is reused without permission or attri-
bution. Under the proposals the license, CC-BY, under
which narrative text of articles is published will not
change. If data published in journals are available under
CC0, re-users of the data should still cite their sources
whenever it is technically possible to do so. Software,
such as CrossCheck, exists to detect plagiarism, and peer
reviewers can also detect plagiarism. Both peer review
and plagiarism detection software are agnostic to con-
tent licenses. The Creative Commons have rightly de-
scribed plagiarism as “a completely orthogonal issue to
copyright infringement” [10].
Question: Do authors need to publish more data than
they publish already?
Response: We are not requiring authors to publish
more of their data. The change in license only affects
data that authors choose to submit to our journals for
open access publication, and does not require release of
any other data or a change in license of any data not
submitted to the journal. Therefore, authors, editors and
their communities remain in control of what content
they publish. CC0 is the default term for data which are
already being or will be made available open access.
However, BioMed Central supports data sharing and re-
lease from all areas of research, where this is possible.
Question: What if authors are not allowed, by their
funders or employers, to use CC0 for any of their pub-
lished work?
Response: Where legitimate reasons exist for authors
to be unable to apply CC0 to their published data, it is
possible to opt out and use a non-standard license. This
process already happens in journal publishing. Com-
monly figures, tables or charts are reproduced, with per-
mission, in journal articles from sources which are
licensed differently to the secondary publisher’s terms –
and statements to this effect included in articles. When
submitting work to journals authors already have read
the publisher’s standard copyright and license agreement
and, if they cannot agree to the terms, query these be-
fore submission or publication. Some scientists funded
by the World Health Organization, UK Government,
and US Government already have agreements with pub-
lishers to use a non-standard copyright statement in
their open access articles.
Question: Will patient privacy be put at risk?
Response: Protecting human subjects’ right to privacy
is a core principle of ethical research, and of the laws of
many countries. The introduction of CC0 does not affect
processes and laws relating to informed consent, privacy,
and consent for publication. Changing the licensing of
freely available data neither affects what human subjects
data are submitted for publication nor the accessibility of
any anonymized human data which are published [11].
Question: Will articles receive fewer citations?
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means that legally there is no requirement for attribu-
tion of the original author(s) if the data are copied,
redistributed or reused. However, anyone reusing data
should, whenever technically feasible, still cite the ori-
ginal author(s). Attribution is a legal requirement of
copyright law and citation is a cultural norm in scholar-
ship which ensures scientists receive credit for their
work. But the two concepts are different and often con-
fused. Citing sources is an established cultural norm in
scholarship which has persisted for centuries in the ab-
sence of legal requirements for citation. Attribution and
citation can sometimes be achieved in the same manner
but the practices serve different purposes (see the table
in Hrynaszkiewicz & Cockerill [3] for practical exam-
ples). Attribution does not always equal citation, and
credit in scholarship is assigned by the latter.
Placing data or any other content in the public domain
is not incompatible with the generators of the data
requesting – non-legal – conditions for its reuse. For ex-
ample, the International Stroke Trial investigators, who
published a large clinical trial dataset under CC-BY, add-
itionally requested “any publications arising from the use
of this dataset acknowledges the source of the dataset, its
funding and the collaborative group that collected the
data” [12]. Two other research groups have since reused
the data [13].
We are not aware of empirical evidence that applying
CC0 to published data results in scientists receiving
fewer citations to or less credit for their articles. In fact,
the limited evidence available on citation share for pub-
lished articles which provide full access to supporting
data compared to articles with no supporting data sug-
gests that publishing data with journal articles and enab-
ling reuse increases the number of citations. This has
been found in microarray research [14], astronomy and
the marine sciences [15], although these studies did not
evaluate different content licenses – only accessibility.
Furthermore, the attribution requirement is only
waived for published data, which includes data in add-
itional files and within journal articles. The remainder of
each article will retain a CC-BY license.
Question: What incentive is there for the original au-
thor(s) to use CC0 instead of CC-BY?
Response: The impact of different licenses for data on
citation of datasets and related scholarly works has not
yet been established. However, since public domain dedi-
cation maximizes the potential for data discovery and re-
use we might reasonably hypothesize that open licensing
might increase individual credit and citations. There is
evidence [14-16] that sharing of research data underlying
journal articles increases citation share and increases re-
producibility of results [17]. A lack of datasets which can
be readily shared and combined – i.e., are in the publicdomain under an open data license – has been identified
as hampering progress in evolutionary magnetic reson-
ance imaging (evoMRI) research [18]. Data supporting
publications and placed in the public domain in fields fa-
cing this problem promote collaboration between re-
search teams and furthers progress.
Question: Why do we need to change the license if
copyright already does not apply to data?
Response: We are part of a global research and open
access publishing enterprise and whether copyright ap-
plies to data varies depending on the legal jurisdiction.
In the US this concern may be valid as copyright does
not apply to facts (and data are numerical representa-
tions of facts), only to the way in which they are
presented. However, in Australia copyright could apply
to data [19] as the focus of the law is on originality ra-
ther than creativity. Furthermore, public domain dedica-
tion is not just about copyright. Applying CC0 aims at
removing all legal barriers to sharing and reuse of con-
tent, and so waiving not just copyright but also all re-
lated and neighboring rights, such as patents and
trademarks, maximizes the potential for reuse.
Another important reason for implementing explicit
and clear open data licensing is about removing ambigu-
ity. For data reuse to be efficient, humans and machines
need content to be clearly licensed. The alternative,
making case-by-case assessments and checking with in-
dividual data publishers and authors about the license or
copyright status of individual data packages, does not
scale. Being clear about licensing also reduces the risk
that an individual or organization publishing or reusing
data in good faith does not become involved in unin-
tended legal debate in the future.
Question: Will data storage problems be created for
the publisher or authors?
Response: Our open data policy is purely about chan-
ging the license for data published in BioMed Central
journals. There are no plans to increase the maximum
additional file size and number of files which can be
published (virtually unlimited files of up 20 Mb per file).
Therefore data storage is unaffected by the policy.
Limitations of the consultation
The consultation ran for two months and was featured
on the BMC Blog and BMC Update newsletter. We also
contacted the editors of all our independent journals.
The response rate to the consultation was therefore
fairly low, and as with all surveys and consultations re-
sponder bias should be considered. Perhaps we could
hypothesize that many scientists read the proposals and
understood that what we proposed does not represent a
major change (it doesn’t), but this is speculative. We are
aiming to provide clarity about the copyright status of
content which scientists already choose to make open
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cial use. But if at the same time more awareness is raised
of the opportunities resulting from more open science,
this could be considered an indirect benefit.What next
We remain committed to implementing open data com-
pliant licensing in our journals and are now working
on the technical and legal details. We defined in our
September article the minimum and desirable publishing
platform developments that would be needed.
However, one aspect of the public consultation which
attracted few responses was the question of “How do
you define data?”. This is important as applying a legal
tool selectively to different parts of a published work
could, in principle, necessitate defining which parts are
covered by which tool. But data are notoriously difficult
to define. Implementing this at scale in material submit-
ted to journals requires the process to be automated,
without the need for humans to evaluate each file type
and its contents. Publishers receive a huge variety of file
types as supplementary file submissions. There are a
number of file types which are more obviously associ-
ated with data but comprehensively defining them might
be an insurmountable challenge.
Initially, we will therefore simply change our policy so
that authors apply CC0 by default to all data included in
each article, its reference list(s) and its additional files
(including tables, graphical data points, bibliographic
data, and machine-harvestable terms), unless an author
has opted out. This implementation of an “open by de-
fault” license for data makes the approach scalable. So
our new standard license statement will read in each
article:
“© 2013 < Author > et al. This is an Open Access
article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.
org/licenses/by/2.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided
the original work is properly cited. The Creative
Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/)
applies to the data made available in this article,
unless otherwise stated.”
This approach allows re-users of data (humans and
machines) to interpret the license in their – in all likeli-
hood good – understanding of data definitions for their
area of research. This approach will be complemented
by providing even more practical examples of different
data types and (re)use cases in our guidelines and Fre-
quently Asked Questions, which will grow over time.Technology will further enhance the process of
attaching licenses to different parts of published articles.
Any additional files uploaded on journal submission sys-
tems specifically as or tagged as supporting data files
would be tagged with CC0 as the default. This human
and machine readable licensing information can then at-
tach to and follow each file through to eventual publica-
tion and ideally be embedded within the files
themselves.
On a related note, we also intend to upgrade the attri-
bution component of BioMed Central‘s license agree-
ment from CC-BY 2.0, which we introduced as our
standard license in 2004, to CC-BY 4.0 [20] shortly after
the new version will be released following final discus-
sions at the Creative Commons Global Summit which
takes place in August 2013. Creative Commons update
their licenses every few years in the light of user feed-
back and technical and legal developments, and CC-BY
4.0 is such an update to the Attribution license.
Appendix
Background to the consultation
The focus of our work on promoting data sharing and
data reuse has been about removing barriers: making it
easier to share science and helping to demonstrate the
value of more open approaches to scientific discourse,
when these are compatible with community norms, eth-
ical codes and legal statutes. Part of a publisher’s role is
to help the scientific community and funders to receive
collective community benefit from published science.
Open access to journal articles and underlying data, with
the use of appropriate open content licenses, should en-
sure both society and individuals gain the maximum
benefit from scientific endeavors. But ‘open’ in open
data, and open access, means much more than just ac-
cess [21].
In 2010 BioMed Central publicly endorsed the Panton
Principles for Open Data in Science and issued a draft
open data statement which made some initial proposals
as to how these principles could be put into practice in
journal publishing [22]. At that time, no data published
in online journals and their supplements were compliant
with these principles. Central to the Panton Principles is
ensuring data can be reused, integrated and built upon
with the minimum of restrictions. For data which are or
which will be free to access online this means dealing
with licensing, copyright and intellectual property – and
placing data in the public domain by waiving copy and
other rights. A widely-accepted tool for doing this is the
Creative Commons CC0 waiver. Data repositories such
as Dryad and Figshare already use CC0 for data deposits.
In our draft open data statement we proposed that in
the future all authors could agree that any data which
they submit to a journal for open access publication
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and tables) would be placed in the public domain with a
CC0 waiver.
This approach was supported by the consensus of at-
tendees of our Publishing Open Data Working Group
meeting, convened in June 2011 after we publicly invited
the scientific and publishing community to help us put
the Panton Principles into practice. However, the con-
sensus of the working group was also that much more
detail needed to be added to the proposal. The case for
why authors should do this and the implications of the
changes for authors and publishers needed to be made.
Therefore, in 2012, with the input of several members of
the working group, a detailed paper was published in
BMC Research Notes [3]. We then invited the public to
comment on the proposals, which were extended to ex-
plicitly include opening up bibliographic data, and sys-
tematically contacted editors of our journals requesting
their and their communities’ views. We received com-
ments directly on the blog announcement although the
majority were received by email.
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